PL3845524T3 - Związki kwasu benzoesowego i sposób ich wytwarzania oraz ich zastosowania - Google Patents

Związki kwasu benzoesowego i sposób ich wytwarzania oraz ich zastosowania

Info

Publication number
PL3845524T3
PL3845524T3 PL19772121.0T PL19772121T PL3845524T3 PL 3845524 T3 PL3845524 T3 PL 3845524T3 PL 19772121 T PL19772121 T PL 19772121T PL 3845524 T3 PL3845524 T3 PL 3845524T3
Authority
PL
Poland
Prior art keywords
preparation
application
benzoic acid
acid compounds
compounds
Prior art date
Application number
PL19772121.0T
Other languages
English (en)
Inventor
Junbiao Chang
Jinfa Du
Kaikai ZHU
Kai Wang
Original Assignee
Henan Genuine Biotech Co., Ltd.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Henan Genuine Biotech Co., Ltd. filed Critical Henan Genuine Biotech Co., Ltd.
Publication of PL3845524T3 publication Critical patent/PL3845524T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/78Benzo [b] furans; Hydrogenated benzo [b] furans
    • C07D307/82Benzo [b] furans; Hydrogenated benzo [b] furans with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D307/83Oxygen atoms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid
    • A61K31/192Carboxylic acids, e.g. valproic acid having aromatic groups, e.g. sulindac, 2-aryl-propionic acids, ethacrynic acid 
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/335Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/365Lactones
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/14Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/48Preparations in capsules, e.g. of gelatin, of chocolate
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00Drugs for disorders of the muscular or neuromuscular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/08Antiepileptics; Anticonvulsants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/10Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/01Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups
    • C07C65/17Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing hydroxy or O-metal groups containing rings other than six-membered aromatic rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/307Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by introduction of halogen; by substitution of halogen atoms by other halogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C67/00Preparation of carboxylic acid esters
    • C07C67/30Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group
    • C07C67/333Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton
    • C07C67/343Preparation of carboxylic acid esters by modifying the acid moiety of the ester, such modification not being an introduction of an ester group by isomerisation; by change of size of the carbon skeleton by increase in the number of carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C69/00Esters of carboxylic acids; Esters of carbonic or haloformic acids
    • C07C69/76Esters of carboxylic acids having a carboxyl group bound to a carbon atom of a six-membered aromatic ring
    • C07C69/78Benzoic acid esters
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D307/00Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/77Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D307/87Benzo [c] furans; Hydrogenated benzo [c] furans
    • C07D307/88Benzo [c] furans; Hydrogenated benzo [c] furans with one oxygen atom directly attached in position 1 or 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00Systems containing only non-condensed rings
    • C07C2601/02Systems containing only non-condensed rings with a three-membered ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL19772121.0T 2018-03-19 2019-03-14 Związki kwasu benzoesowego i sposób ich wytwarzania oraz ich zastosowania PL3845524T3 (pl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN201810225467 2018-03-19
PCT/CN2019/078059 WO2019179346A1 (zh) 2018-03-19 2019-03-14 苯甲酸类化合物及其制备方法和应用

Publications (1)

Publication Number Publication Date
PL3845524T3 true PL3845524T3 (pl) 2022-10-24

Family

ID=66487918

Family Applications (1)

Application Number Title Priority Date Filing Date
PL19772121.0T PL3845524T3 (pl) 2018-03-19 2019-03-14 Związki kwasu benzoesowego i sposób ich wytwarzania oraz ich zastosowania

Country Status (7)

Country Link
US (1) US11578049B2 (pl)
EP (1) EP3845524B1 (pl)
CN (1) CN109776466B (pl)
ES (1) ES2927538T3 (pl)
PL (1) PL3845524T3 (pl)
PT (1) PT3845524T (pl)
WO (1) WO2019179346A1 (pl)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN112794831B (zh) * 2021-04-06 2021-07-27 北京理工大学 3-(3′-羟基丁基)异苯并呋喃-1(3h)-酮衍生物及其组合物、制备方法和用途
CN117159531B (zh) * 2023-07-28 2026-02-03 平原实验室 布罗佐喷钠在制备防治老年性痴呆药物中的应用
CN118978500A (zh) * 2024-08-02 2024-11-19 苏州摩笛尔科技有限公司 一种靶向含氟丁苯酞、合成方法及其应用

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1182127C (zh) * 2000-06-28 2004-12-29 中国医学科学院药物研究所 新的取代的2-苯并[c]呋喃酮化合物,其制备方法以及包含它们的药物组合物
CN1243541C (zh) * 2002-05-09 2006-03-01 中国医学科学院药物研究所 2-(α-羟基戊基)苯甲酸盐及其制法和用途
CN100540523C (zh) * 2004-06-17 2009-09-16 北京天衡药物研究院 L-2-(α-羟基戊基)苯甲酸盐及其制法和用途
CN101054346A (zh) * 2006-04-13 2007-10-17 温建波 一组新化合物及其组合物的制备方法和用途
CN100554259C (zh) * 2007-04-12 2009-10-28 郑州大学 2-苯并[c]呋喃酮化合物及其应用
CN101337955B (zh) * 2008-08-13 2012-05-09 石药集团中奇制药技术(石家庄)有限公司 一种制备高光学纯度3-取代手性苯酞类化合物的方法
CN101402565B (zh) * 2008-11-14 2012-07-04 郑州大学 卤代2-(a-羟基戊基)苯甲酸盐及其制法和用途
CN102397272B (zh) * 2010-09-17 2013-08-14 石药集团恩必普药业有限公司 丁基苯酞及其衍生物在制备预防和治疗als的药物中的应用
WO2013102935A2 (en) * 2012-01-03 2013-07-11 Council Of Scientific & Industrial Research Cu-MEDIATED ANNULATION FOR THE EFFECTIVE SYNTHESIS OF 3-SUBSTITUTED PHTHALIDES
CN104086399B (zh) * 2013-07-17 2016-08-24 浙江奥翔药业股份有限公司 5-溴-2-(α-羟基戊基)苯甲酸钠盐的不同晶型及其制备方法

Also Published As

Publication number Publication date
EP3845524A1 (en) 2021-07-07
CN109776466A (zh) 2019-05-21
EP3845524B1 (en) 2022-08-31
CN109776466B (zh) 2023-01-31
WO2019179346A1 (zh) 2019-09-26
ES2927538T3 (es) 2022-11-08
EP3845524A4 (en) 2021-07-21
US20210002244A1 (en) 2021-01-07
PT3845524T (pt) 2022-09-28
US11578049B2 (en) 2023-02-14

Similar Documents

Publication Publication Date Title
IL285178A (en) Compounds and uses thereof
HUE058687T2 (hu) Azonnali elõkészítés
PL3838888T3 (pl) Triestry kwasu cykloheksanotripropionowego
PL3761980T3 (pl) Związki aminokwasowe i sposoby zastosowania
IL282998A (en) Pyridazinone compounds and uses thereof
PT3259253T (pt) Sulfonilureias e compostos relacionados e uso dos mesmos
EP3473614A4 (en) SULFONIC ACID ESTER COMPOUND AND USE THEREOF
IL278122B1 (en) Pteridinone compounds and uses thereof
EP3473613A4 (en) SULFONIC ACID ESTER COMPOUND AND USE THEREOF
EP3250367A4 (en) ACTIVE CALIBRATION
EP3808783A4 (en) Novel crosslinked alginic acid
DK3484457T3 (da) Topisk formulering til fremme af sårheling
PL3261437T3 (pl) Grzybobójcze związki i kompozycje
IL284514A (en) Halo-allylamine compounds and use thereof
IL285118A (en) Compounds and uses thereof
EP3600279A4 (en) 1-amino-1-cyclopropanecaboxylic acid formulations
EP3830103C0 (en) FLUORINATED BILE ACID DERIVATIVES
IL280533A (en) Topical composition
EP3600280A4 (en) 1-AMINO-1-CYCLOPROPANECARBOXYL ACID HYDROCHLORIDE FORMULATIONS
PL3986419T3 (pl) Pochodne kwasu boronowego i ich zastosowania terapeutyczne
PL3452441T3 (pl) Pochodne kwasu alfa-truksylowego i ich kompozycje farmaceutyczne
IL282157A (en) Compounds and therapeutic uses thereof
IL264445A (en) Compounds and compositions and uses thereof
PL3845524T3 (pl) Związki kwasu benzoesowego i sposób ich wytwarzania oraz ich zastosowania
IL287560A (en) Mrna formulation